Amyloid-β Seeding as a Basis for a Blood Test for Alzheimer's Disease

From the abstract

Blood tests to assess Alzheimer's disease risk and progression exist, for example based on the presence of circulating varieties of tau protein, but there is a great deal of room for improvement. Researchers here provide evidence for an approach to the measurement of very small amounts of misfolded amyloid-β in blood to work reasonably well in patients. The amyloid cascade hypothesis continues to steer much of the field of research and development for Alzheimer's disease; misfolded amyloid-β spr